🔗 Share this article

The top legal official in Texas Ken Paxton is filing a lawsuit against the producers of Tylenol, alleging the firms withheld potential risks that the pain reliever created to children's cognitive development.

This legal action arrives thirty days after President Donald Trump promoted an unproven link between taking acetaminophen - also known as paracetamol - throughout gestation and autism in young ones.

Paxton is suing J&J, which previously sold the drug, the only pain reliever suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he said they "deceived the public by making money from discomfort and pushing pills regardless of the risks."

The company says there is insufficient reliable data linking acetaminophen to autism.

"These companies lied for decades, knowingly endangering millions to line their pockets," Paxton, a Republican, stated.

Kenvue commented that it was "seriously troubled by the perpetuation of misinformation on the reliability of paracetamol and the possible consequences that could have on the health of US mothers and children."

On its official site, the company also said it had "consistently assessed the relevant science and there is insufficient valid information that shows a proven link between taking acetaminophen and autism."

Associations acting on behalf of physicians and healthcare providers share this view.

The leading OB-GYN organization has stated acetaminophen - the key substance in Tylenol - is a restricted selection for pregnant women to address discomfort and elevated temperature, which can pose significant medical dangers if ignored.

"In multiple decades of research on the use of acetaminophen in gestation, zero credible investigations has conclusively proven that the use of paracetamol in any period of gestation leads to brain development issues in young ones," the organization commented.

This legal action mentions latest statements from the previous government in asserting the drug is reportedly hazardous.

Last month, the former president raised alarms from public health officials when he told women during pregnancy to "struggle intensely" not to take Tylenol when unwell.

Federal regulators then issued a notice that medical professionals should contemplate reducing the use of Tylenol, while also declaring that "a direct connection" between the drug and autism in young ones has remains unverified.

Health Secretary RFK Jr, who manages the FDA, had promised in spring to undertake "comprehensive study program" that would identify the source of autism in a short period.

But authorities advised that discovering a unique factor of autism spectrum disorder - thought by researchers to be the outcome of a intricate combination of inherited and surrounding conditions - would not be simple.

Autism spectrum disorder is a type of permanent neurological difference and condition that impacts how people perceive and relate to the world, and is recognized using physician assessments.

In his lawsuit, the attorney general - aligned with the former president who is running for the Senate - asserts Kenvue and J&J "intentionally overlooked and sought to suppress the science" around acetaminophen and autism spectrum disorder.

The lawsuit attempts to require the companies "remove any marketing or advertising" that asserts acetaminophen is reliable for pregnant women.

This legal action parallels the complaints of a group of parents of minors with autism and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in recently.

Judicial authorities rejected the legal action, saying research from the family's specialists was not conclusive.